IMR-32 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | IMR-32 is a human neuroblastoma cell line derived from the adrenal medulla of a child diagnosed with neuroblastoma, a malignant tumor originating from neural crest cells. These cells exhibit characteristics of immature neuronal cells, making them a valuable model for studying neuronal differentiation, neuroblastoma pathogenesis, and the molecular mechanisms underlying neurodevelopmental processes. The IMR-32 cells have a high capacity for proliferation and retain the ability to synthesize catecholamines, particularly dopamine and norepinephrine, which are essential neurotransmitters in the nervous system. IMR-32 cells display a diploid karyotype with specific chromosomal aberrations commonly associated with neuroblastoma, such as amplification of the MYCN oncogene. This feature makes them particularly useful for research into the genetic and molecular drivers of neuroblastoma, including MYCN's role in tumorigenesis and progression. Additionally, IMR-32 cells are employed in drug screening assays to evaluate the efficacy and cytotoxicity of potential therapeutic agents targeting neuroblastoma. However, it is crucial to note that these cells are intended solely for in vitro research purposes and are not suitable for any therapeutic or in vivo applications. |
|---|---|
| Organism | Human |
| Tissue | Brain |
| Disease | Neuroblastoma |
| Metastatic site | Abdomen |
| Synonyms | IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
Characteristics
| Age | 13 months |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Fibroblast-like |
| Cell type | Neuroblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | IMR-32 (Cytion catalog number 300148) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0346 |
Biomolecular Data
| Isoenzymes | G6PD, B |
|---|---|
| Virus susceptibility | Vesicular stomatitis (Indiana), herpes simplex, vaccinia, coxsackievirus B3, poliovirus 3 (poorly) |
| Virus resistance | Echovirus 11 |
| Reverse transcriptase | Negative |
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 x 104 cells/cm2 |
| Fluid renewal | Every 3 to 5 days |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300148-040724 | Certificate of Analysis | 23. May. 2025 | 300148 |
| 300148-131123 | Certificate of Analysis | 23. May. 2025 | 300148 |
| 300148-613 | Certificate of Analysis | 23. May. 2025 | 300148 |